This page lists information on applications for centralised marketing authorisations for human medicines that are under evaluation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
The list of medicines under evaluation is updated each month. It includes the international non-proprietary names (INN) and therapeutic areas for all new innovative medicines under evaluation by the CHMP. For generic and biosimilar medicines, it includes the INN (active moiety only, with no information on salt, ester or derivative) and therapeutic area.
Table of contents
|Document(s)||Language||Status||First published||Last updated||Effective Date|
|Applications for new human medicines under evaluation by the CHMP: February 2017||(English only)||2017-02-13|
|Applications for new human medicines under evaluation by the CHMP: January 2017||(English only)||2017-01-16|